(Q35600418)

9 August 2017

1 reference

title

Does homocysteine cause hypertension? (English)

1 reference

9 August 2017

Coen D A Stehouwer

1

1 reference

PubMed ID

14656018

9 August 2017

Coen van Guldener

series ordinal

2

1 reference

9 August 2017

1 November 2003

1 reference

Clinical Chemistry and Laboratory Medicine

9 August 2017

1 reference

9 August 2017

41

1 reference

9 August 2017

11

1 reference

9 August 2017

1408-1411

1 reference

Cardiovascular protection and blood pressure reduction: a meta-analysis

9 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Total plasma homocysteine is associated with hypertension in Type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Homocysteine and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Hyperhomocysteinemia induces renal hemodynamic dysfunction: is nitric oxide involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Homocysteine enhances TIMP-1 expression and cell proliferation associated with NADH oxidase in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.216

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.216

1 reference

9 August 2017

1 reference

PubMed ID

14656018